NeuroOne's First Implant of OneRF Ablation Electrodes

Congratulations on this surgery that I understand occurred just as recently as yesterday. And I want to get your perspective on how big a seismic shift this is, is for you. I I think it’s a tremendous, tremendous accomplishment for the company. But I also think for the field, I mean what patients have been dealing with that undergo these surgeries is they’ve, they’ve had to come in for an invasive diagnostic surgery where the surgeon tries to locate the problematic area in the brain. And then those patients would be sent home and then rescheduled for a therapeutic surgery where another device would have to be placed to remove the tissue. And what we’re able to do now with this technology is use the same device to do both in the same hospitalization which we think will cut down on hospitalization surgeries and and even cost for the procedure. So we we think this is a a major accomplishment putting chips or other devices within the brain, the oxygen seems to have been sort of sucked out of the room by companies such as Neuralink. And I’m interested in your perspective of actually put the context around this. How long has this been happening? How long have we been putting bits of equipment devices into the brain to be ensuring that we know really what’s going on there for actually many, many years. So it’s it’s not new for brain mapping and even with companies like Neuralink and Synchron, you know putting BCI devices in patients to help them move a computer mouse by just thinking that that’s been done for quite a long time. I think the eloquence of how they’re doing it now is much, much different by using wireless systems or less invasive systems where you’re able to to place the devices through a blood vessel. So that that’s really where the advancements have come. Recently, you’re putting electrodes in the brain and I’m interested in exactly what the different products are that you’re developing and what they actually do. Yeah. So the electrodes that we have and the goal of this company was to always be able to use the same device do mapping to do ablation and to do stimulation, which is another therapeutic treatment for for conditions like Parkinson’s disease and and even epilepsy. But really what excites me about the future of this technology is not just the things that companies like Neuralink are trying to accomplish, which is really be able to help people that are paralyzed. I think the next wave of utilization for devices like ours is to be able to deliver new gene therapies and drugs and deliver them precisely to the part of the brain that’s causing the issues for patients. And then also be able to simultaneously monitor the efficacy and then other indications, which I think again will be big opportunities or Alzheimer’s primarily. And then also conditions like severe depression. Scientists have found the areas of the brain that control emotions. And there’s also been some some really exciting work done by the Mayo Clinic on improving short term memory using electrodes like this for Alzheimer’s patients.